In a study on acute primary angle closure, it was demonstrated that the anterior placement of the ciliary body and ciliary body thickness were positively correlated with choroidal thickness [1] . Knowledge of the effects of acute primary angle closure on the choroid is important because the choroid plays important roles in the eye. We would like to highlight aspects of the study design which may have bearing on the result interpretation.
The authors mentioned that the effects of diurnal variations were reduced by performing all examinations at about 1000 hours. There are studies that have used spectraldomain optical coherence tomography to demonstrate diurnal variation of choroidal thickness [2, 3] . The difference between the maximum and minimum choroidal thickness exceeded 30 µm [2, 3] . In addition, a sub-analysis of subjects with thicker choroids (defined as ≥400 µm) in one paper [2] , demonstrated that the mean amplitude was even larger (43.1 µm) with a maximum of 59 µm. While considering diurnal variation is an important consideration, a consequence of this is that the choroidal thickness measurements would be made at different times from the initial APAC attack. This is likely to influence the correlation of choroidal thickness with the anterior placement of the ciliary body and ciliary body thickness. However, if diurnal variation is to be considered, this is likely a limitation which cannot be overcome.
Another important consideration is the topographic variation of the choroid. The choroid is a complex, threedimensional structure comprising an anastomosing blood vessel network. Studies have reported significant variation of choroidal thicknesses at different regions of the macula using the Early Treatment Diabetic Retinopathy Study (ETDRS) grid [4, 5] . In this study, the mean overall regional thicknesses of the choroid in the 36 sectors of the sweptsource grid were calculated. However, because this is different from the choroidal thicknesses reported in earlier studies, comparison of the current study with similar studies is difficult. It would be interesting to determine if anterior placement of the ciliary body and ciliary body thickness are still positively correlated with choroidal thickness at the various ETDRS sectors. This would facilitate comparison with other studies.
In conclusion, we congratulate the authors on an interesting paper.
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As the comment mentioned, in our study, the diurnal variations was an insurmountable confounding factor to the thickness of choroid and other parts of uvea. As we know, APAC attack usually happened at night, which was speculated be associated with dilating pupil as a result of dim lighting [2] . The attacks in our study were almost in the same situation. The examinations performing at the same timepoint was the most simple and effective way to reduce the confounding effect. Meanwhile, the previous studies about the diurnal variations of choroidal thickness (CT) found that the maximum at 0300 hours, and the minimum at 1800 hours, which meant the CT gradually expand after sunset until midnight [3] . We speculate the trend of choroid expanding might play a role in the angle closure.
Second, our research team has recently published several articles about the topographic variation of the choroid. We found that POAG/PACD eyes had a thicker anterior choroid than the controls. However, there was no significant difference in the posterior choroidal thickness among the groups. The anterior choroid might play a role in the pathogenesis of glaucoma [4] . Meanwhile we found that Valsalva manoeuvre did not affect the posterior choroid, but it did cause thickening of the anterior choroid and the ciliary body, both of which led to a larger anterior placement of the ciliary body and a narrowed anterior chamber. The anterior (but not the posterior) choroid could be related to IOP elevation and a narrowed anterior chamber in primary angle closure diseases [5, 6] . The relationship between the anterior choroid and the blood pressure need further investigation.
Finally As the absolute number of elderly people rises and with the advent of OCT scanners, community optometrists (COs) are seeing more abnormalities in their routine practice. Furthermore hospital eye services face a challenge keeping up with demand. Project ECHO (Extension for Community Healthcare Outcomes) is an educational model that partners primary healthcare providers with specialists, creating a 'community of practice'. ECHO has been applied to many areas of healthcare (http://echo. unm.edu accessed June 2018), but not previously to eye care. We describe the first ECHO project involving ophthalmologists (in the 'hub') and COs (in the 'spokes'). Some COs want enhanced roles: ECHO is a potential vehicle contributing to governance of shared eye care. The aims of this study were to assess the feasibility, acceptability and impact on knowledge and self-reported efficacy of the eye care ECHO and explore participants' impressions of it. A mixed-methods prospective cohort study was performed on 12 ECHO sessions, held weekly. Each session had the same 21 COs, and in the hub one of two ophthalmologists who focused on macular disease or glaucoma. A talk was given by a hub-member, then COs presented cases. Due to the small sample size, descriptive statistics and non-parametric tests were used. Focus group data was analysed using thematic analysis.
Of the 21 spoke optometrists, 29% (6/21) had OCT scanners. In a knowledge assessment, marks improved from the pre-ECHO test (median 25/38, range 19-31), to the post-ECHO test (median 27/38, range 21-33) (z = −2.3, p = 0.019). Ninety-one percent (10/11) of COs who responded indicated they had learnt "a lot" through ECHO and 70% (7/10) agreed that participating in ECHO had improved the care they provide for patients "a lot". Analysis of transcribed focus group discussions led to identification of three themes: professional and clinical learning occurring, expectations being exceeded, and suggestions for future ECHO sessions. An exemplar quotation was: "…certainly for me it will reduce some unnecessary referrals but it will also help me pick up on things that I really need to refer". Also 'diffusion of learning' occurred: "I found other colleagues asking me things and it was something that I could maybe bring as a question in ECHO, so the whole team did learn, and because I work in different practices, that was spread among different practices too."
Though numbers are small, the data suggest that ECHO was feasible, acceptable and could be an effective training modality. Focus groups discussions by participants in the ECHoES trial (unrelated to Project ECHO) revealed potential barriers to the deployment of optometrists in hospital-based ophthalmic care, including the need for "buy in" for optometric involvement [1] . 'Buy in' was suggested to depend on training delivered in a way that would reassure the ophthalmologist: ECHO may provide this.
As the ECHO model is replicable, the challenge would be to nurture local relationships formed to ensure sustainable participation, and eventually to incorporate ECHO's multidisciplinary networks permanently into service delivery in a way that is acceptable to all, safe and demonstrably benefits patients.
Introduction
Endophthalmitis following intravitreous anti-vascular endothelial growth factor (VEGF) injection is a rare sight-threatening condition. Several Western references suggest lower rates of post-injection endophthalmitis can be achieved without topical antibiotic prophylaxis [1] [2] [3] . However, a majority of physicians in the Asia-Pacific region still prescribe antibiotic prophylaxis [4] , anecdotally stating concern that differences in environmental factors (e.g., tropical climates) or patient factors in the region might cause higher risk of endophthalmitis, comparing to the Western settings, to warrant this prophylaxis, despite little scientific rationale supporting such use. To our knowledge, little is known regarding incidence of post-injection endophthalmitis without antibiotic prophylaxis in a developing countries in Asia or elsewhere. Therefore, this study determined incidence of postinjection endophthalmitis with vs. without topical antibiotic prophylaxis at a university-based practice in Northern Thailand.
Materials and methods
IRB-approved prospective case series of patients receiving anti-VEGF injections at Chiang Mai University Hospital between May 2015 and September 2016 with follow-up anticipated for ≥3 weeks after injections were recruited. Before injections, study eyes were examined by slit-lamp biomicroscopy, ensuring no intraocular inflammation. Endophthalmitis was evaluated at 4 ± 1 weeks after the injection, and defined as severe inflammation in both anterior chamber and vitreous cavity associated with pain, redness, or decreased vision, regardless of whether subsequent cultures were positive. A standardized intravitreous anti-VEGF injection protocol was strictly applied, including use of sterile drape, sterile eyelid speculum, sterile glove, procedure mask, and application of povidone-iodine, twice, over eyelid and conjunctival sac, and over injection site using a povidone-iodine soaked cotton tip for ≥30 s before injection.
Subsequently, participants received or did not receive topical antibiotics depending on their physicians' preferences. Three of six retina specialists (DP, PK, NI) always prescribed antibiotics (Tobramycin®) before or after injections for 5-7 days; the other three (JC, NW, VC) did not prescribe any antibiotics as part of standard care.
Results
Of 4263 injections (1043 participants) meeting eligibility criteria, 1407 (33%) received antibiotic prophylaxis, and 2856 (67%) did not receive any antibiotics. Demographics are shown in Table 1 . There was one case of culture-negative post-injection endophthalmitis, which subsequently underwent vitrectomy, among eyes a For example, agricultural workers, construction workers b DME diabetic macular edema, PCV polypoidal choroidal vasculopathy, NV AMD neovascular age-related macular degeneration, RVO retinal vein occlusion, ME macular edema, PDR proliferative diabetic retinopathy, VH vitreous hemorrhage, anti-VEGF anti-vascular endothelial growth factor c Bevacizumab was re-packaged in sterile fashion by the hospital pharmacy department into multiple doses of 1.25 mg/0.05 ml. Each dose was stored in a sterile insulin syringe, while ranibizumab (0.5 mg/0.05 ml) and aflibercept (2.0 mg/0.05 ml) were prepared by physicians at the time of each injection receiving antibiotics (1/1407 injections; 0.07%). No endophthalmitis occurred among eyes not receiving antibiotics (0/2856 injections; 0%) for a difference of 0.07% (95% confidence interval: −0.12 to 0.26%, P = 0.728; Table 2 ).
Discussion
To our knowledge, this study is among the first to explore an incidence of post-injection endophthalmitis when no antibiotic prophylaxis was given in a developing-country setting. The setting, a government hospital which mainly serves lower socioeconomic patients within geographically tropical climates, may be a good representative for individuals believed by some to be at higher risk for post-injection endophthalmitis in developing countries. The results, though not a randomized clinical trial, did not reveal an increased incidence of endophthalmitis in eyes not receiving antibiotic prophylaxis, similar to Western reports [1] [2] [3] . These data support continued use of povidone-iodine for ≥30 s prior to intravitreous injection [5] but not topical antibiotics for prophylaxis against post-injection endophthalmitis.
Funding Funding of this study was provided by Research Committee, Faculty of Medicine, Chiang Mai University, and unrestricted donations to Johns Hopkins University for retina research. The sponsor had no role in the design or conduct of this research. Morbidity and mortality (M&M) meetings drive learning from clinical outcomes and improve service delivery in surgery [1] . They are regular scheduled meetings that discuss adverse surgical outcomes for patients and were originally designed for surgical training. M&M meetings are common place in other surgical specialties and are recommended by the Royal College of Surgeons as part of maintaining and improving patient safety [2] . However, M&M practice appears to be lacking in UK ophthalmology with no recommendations from the Royal College of Ophthalmologists or research into its potential benefits. We present a novel method of integrating M&M meetings to ophthalmology practice which has been running in our department since November 2016. We also present a qualitative analysis of its impact on the department since its inception.
Compliance with ethical standards
To collect M&M incidents, we took a simple twopronged approach: a 'glitchbook' was placed in the ophthalmic theatre to prospectively capture at source any surgical complications; in addition, an email address was created to capture M&M in the clinic setting. In both methods, incidents are reported by the surgeon and/or any auxiliary member of the team.
The M&M meeting was integrated into the departments by two monthly audit meetings to reduce the administrative burden of a separate M&M meeting. These meetings included the wider multidisciplinary team: consultants, trainees, nursing staff and auxiliary staff. Each incident collected is presented by the operating surgeon, which can be in the form of a short description of events, through to a full presentation with a video of the operation. Following the presentations of the case, an open and reflective discussion about the surgical issues occur with involvement of the whole team. In each case, learning points and reflections are noted and any changes needed are implemented and discussed at the next meeting.
A qualitative analysis involving semi-structured interviews and questionnaires was performed to investigate the impact of M&M meetings on the department. There were multiple themes that arose from this study: training and education, cultural change and improving patient care. All surgeons from a trainee to a consultant felt that this was an excellent opportunity and resource for learning. The trainees particularly felt the benefit from experienced feedback from multiple consultants and the chance to hone their presentation skills. All members of the staff felt that the M&M meetings had fostered a blame-free and open culture within the department. The combination of discussing M&M issues and open culture was felt to be strongly driving improvements in patient safety.
Our departments experience of M&M meetings is that we have found it an easy process to implement, with great benefits for training and patient safety. We recommend that UK ophthalmology keeps up with the other specialties and adopts M&M as a standard practice. Health tourism involves intentional travel abroad to obtain private medical care. Motivations are numerous, ranging from financial (affordable treatment) to accessing care unavailable at home [1] . Evidence regarding risk is often limited, sometimes speculative, with little information to guide decisions. It can be biased, based on sensationalist reports, often produced by people with inadequate expertise in such procedures [2] . Most reports reflect individual cases or small case series of problems. Limited studies publishing complication rates for health tourism exist [3] , making risk hard to assess. Complications may be underreported where surgery is associated with financial gain and where patients travel from abroad with poor follow up. A survey by the British Association of Plastic, Reconstructive and Aesthetic Surgery found 37% of members had seen complications of health tourism [4] , raising concerns for an individual's risk but the burden within public healthcare facilities treating complications. Several publications exist on the dangers of cosmetic iris implants [5] , the risks of which have been known for years. We report a case of devastating complications following the procedure.
A 45-year old phakic male had bilateral BrightOcular implantation in 2013 in Jordan (Fig. 1a) . Upon return he periodically developed red, painful, photophobic eyes. Intraocular pressures were elevated during those episodes with associated anterior chamber inflammation. Gonioscopy showed peripheral iris entrapment into the iridocorneal angle (Fig. 1b) . Uveitis, glaucoma, hypheama syndrome was diagnosed. He was asked to return promptly to Jordon for implant removal. After a period of delay, he went as advised. On return, subsequent examination revealed bilateral corectopia, extensive iris atrophy, stretch holes, peripheral anterior synechiae and cataract formation (Fig. 1c,  d ). Intraocular pressures were elevated and cyclodiode was performed. Despite implant removal, progressive endothelial cell loss with corneal decompensation ensued (Fig. 1e) . The patient was listed for Descemets stripping automated endothelial keratoplasty (DSAEK). While awaiting a graft he developed bacterial keratitis (Fig. 1f) , resulting in right eye corneal scarring, and the need for penetrating keratoplasty (PK) bilaterally. The right eye did well (Fig. 1g) , with the graft remaining clear and Snellen best corrected visual acuity (BCVA) of 6/6. The left eye vision recovered, but developed a suture abscess with subsequent graft failure (Fig. 1h) . The patient is awaiting a second PK (with BCVA of hand movements).
Despite previous reports of significant complications, cosmetic iris implants are still advertised across multiple websites and social media platforms in various countries. Some testify the procedure as safe with no patient going blind. We highlight the dangers, reporting potential for bilateral pain, severe sight loss and morbidity. We emphasise visual rehabilitation is not always simple following implant extraction. Cataracts, glaucoma surgery, iris deformation and endothelial cell loss constitute multiple challenges. We join colleagues in calling for international eye surgery communities to increase awareness of this potentially sight threatening issue and informing patients of risks prior to undertaking surgery. Professional governing bodies should encourage reporting of complications from such cosmetic surgery and consider closer monitoring. Better international legislation restricting dangerous surgical practice could be explored. 
